These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12101568)

  • 21. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
    Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
    Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia.
    Cifaldi L; Quaglino E; Di Carlo E; Musiani P; Spadaro M; Lollini PL; Wolf S; Boggio K; Forni G; Cavallo F
    Cancer Res; 2001 Apr; 61(7):2809-12. PubMed ID: 11306448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.
    Lanza-Jacoby S; Miller S; Flynn J; Gallatig K; Daskalakis C; Masferrer JL; Zweifel BS; Sembhi H; Russo IH
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1486-91. PubMed ID: 14693742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
    Bowe DB; Kenney NJ; Adereth Y; Maroulakou IG
    Oncogene; 2002 Jan; 21(2):291-8. PubMed ID: 11803472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of antidiabetic drug diabenol on parameters of biological age, life span and tumor development in NMRI and HER-2/neu mice].
    Popovich IG; Zabezhinskiĭ MA; Egormin PA; Anikin IV; Tyndyk ML; Semenchenko AV; Spasov AA; Anisimov VN
    Adv Gerontol; 2004; 15():80-90. PubMed ID: 15754958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
    Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
    Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.
    Pupa SM; Invernizzi AM; Forti S; Di Carlo E; Musiani P; Nanni P; Lollini PL; Meazza R; Ferrini S; Menard S
    Gene Ther; 2001 Jan; 8(1):75-9. PubMed ID: 11402305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC; Springs AE; Chen WY
    Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stressors and antistressors: how do they influence life span in HER-2/neu transgenic mice?
    Semenchenko GV; Anisimov VN; Yashin AI
    Exp Gerontol; 2004 Oct; 39(10):1499-511. PubMed ID: 15501020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.
    Andrechek ER; Hardy WR; Siegel PM; Rudnicki MA; Cardiff RD; Muller WJ
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3444-9. PubMed ID: 10716706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-aging peptide bioregulators induce reactivation of chromatin.
    Lezhava T; Monaselidze J; Kadotani T; Dvalishvili N; Buadze T
    Georgian Med News; 2006 Apr; (133):111-5. PubMed ID: 16705247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis.
    Rowse GJ; Ritland SR; Gendler SJ
    Cancer Res; 1998 Jun; 58(12):2675-9. PubMed ID: 9635596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression.
    Baturin DA; Alimova IN; Anisimov VN; Popovich IG; Zabezhinski MA; Provinciali M; Mancini R; Franceschi C
    Neuro Endocrinol Lett; 2001 Dec; 22(6):441-7. PubMed ID: 11781542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice.
    Rovero S; Boggio K; Di Carlo E; Amici A; Quaglino E; Porcedda P; Musiani P; Forni G
    Gene Ther; 2001 Mar; 8(6):447-52. PubMed ID: 11313823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithalon decelerates aging and suppresses development of breast adenocarcinomas in transgenic her-2/neu mice.
    Anisimov VN; Khavinson VKh; Alimova IN; Semchenko AV; Yashin AI
    Bull Exp Biol Med; 2002 Aug; 134(2):187-90. PubMed ID: 12459848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.
    Ménard S; Aiello P; Tagliabue E; Rumio C; Lollini PL; Colnaghi MI; Balsari A
    Cancer Res; 2000 Jan; 60(2):273-5. PubMed ID: 10667575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma.
    Smorlesi A; Papalini F; Orlando F; Donnini A; Re F; Provinciali M
    Gene Ther; 2005 Sep; 12(17):1324-32. PubMed ID: 15944732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice.
    Cool M; Jolicoeur P
    Cancer Res; 1999 May; 59(10):2438-44. PubMed ID: 10344755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haploinsufficiency of the Nijmegen breakage syndrome 1 gene increases mammary tumor latency and metastasis.
    Wan R; Crowe DL
    Int J Oncol; 2012 Jul; 41(1):345-52. PubMed ID: 22576691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
    Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.